CytoMed Therapeutics Limited Deferred Income Other Than Contract Liabilities
CytoMed Therapeutics Limited (GDTC) had Deferred Income Other Than Contract Liabilities of SGD 3.01 thousand as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:DeferredIncomeOtherThanContractLiabilities · last filed 2026-03-31
- 2025-12-31: Deferred Income Other Than Contract Liabilities 3.01K SGD.
- 2024-12-31: Deferred Income Other Than Contract Liabilities 1.41K SGD.
- 2023-12-31: Deferred Income Other Than Contract Liabilities 2.94K SGD.
- 2022-12-31: Deferred Income Other Than Contract Liabilities 5.60K SGD.
| Period end | Deferred Income Other Than Contract Liabilities |
|---|---|
| 2025-12-31 | 3.01K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 1.41K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 2.94K SGD 20-F · filed 2025-04-28 |
| 2022-12-31 | 5.60K SGD 20-F · filed 2024-04-22 |
| 2021-12-31 | 8.48K SGD 20-F · filed 2023-05-01 |